Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jacot

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
Breast Cancer Research : BCR|June 25, 2009
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancerCatherine Alix-Panabières, Jean-Pierre Vendrell, Monique Slijper, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Nutrients|December 28, 2021
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant ChemotherapyElodie Chartron, Nelly Firmin, Célia Touraine, et al.
Integrative Cancer Therapies|December 23, 2021
Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility StudyKerstin Faravel, Marie-Eve Huteau, Marta Jarlier, et al.
The Journal of Pathology|March 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti, et al.
Pancreas|November 1, 2002
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatinDavid Azria, Marc Ychou, William Jacot, et al.
Molecular Oncology|June 22, 2015
Frequent expression of PD-L1 on circulating breast cancer cellsMartine Mazel, William Jacot, Klaus Pantel, et al.
Cells|July 1, 2020
Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid CancersGhita Chabab, Florence Boissière-Michot, Caroline Mollevi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 10, 2021
[Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?]Béatrice Lognos, Murielle Glondu-Lassis, Pierre Senesse, et al.
Clinical Breast Cancer|April 3, 2026
Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort StudiesEvan Cescon, Pamela Goodwin, Angelique Bobrie, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Breast Cancer Research : BCR|June 25, 2009
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancerCatherine Alix-Panabières, Jean-Pierre Vendrell, Monique Slijper, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Nutrients|December 28, 2021
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant ChemotherapyElodie Chartron, Nelly Firmin, Célia Touraine, et al.
Integrative Cancer Therapies|December 23, 2021
Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility StudyKerstin Faravel, Marie-Eve Huteau, Marta Jarlier, et al.
The Journal of Pathology|March 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti, et al.
Pancreas|November 1, 2002
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatinDavid Azria, Marc Ychou, William Jacot, et al.
Molecular Oncology|June 22, 2015
Frequent expression of PD-L1 on circulating breast cancer cellsMartine Mazel, William Jacot, Klaus Pantel, et al.
Cells|July 1, 2020
Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid CancersGhita Chabab, Florence Boissière-Michot, Caroline Mollevi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 10, 2021
[Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?]Béatrice Lognos, Murielle Glondu-Lassis, Pierre Senesse, et al.
Clinical Breast Cancer|April 3, 2026
Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort StudiesEvan Cescon, Pamela Goodwin, Angelique Bobrie, et al.
Pageof 22